BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30271885)

  • 1. HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients.
    Burr AR; Harari PM; Ko HC; Chen S; Yu M; Baschnagel AM; Kimple RJ; Witek ME
    Otorhinolaryngol Head Neck Surg; 2018; 3(1):. PubMed ID: 30271885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
    Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of human papillomavirus type 16 status in non-oropharyngeal head and neck cancer: a propensity score matching analysis.
    Zhu Y; Xia X; Gao L; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Ann Transl Med; 2019 Dec; 7(23):759. PubMed ID: 32042775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in Metastatic Oropharyngeal Cancer.
    Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
    Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV Positive Status Is a Favorable Prognostic Factor in Non-Nasopharyngeal Head and Neck Squamous Cell Carcinoma Patients: A Retrospective Study From the Surveillance, Epidemiology, and End Results Database.
    Wu Q; Wang M; Liu Y; Wang X; Li Y; Hu X; Qiu Y; Liang W; Wei Y; Zhong Y
    Front Oncol; 2021; 11():688615. PubMed ID: 34631523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients.
    Rivera-Peña B; Ruíz-Fullana FJ; Vélez-Reyes GL; Rodriguez-Benitez RJ; Marcos-Martínez MJ; Trinidad-Pinedo J; Báez A
    Infect Agent Cancer; 2016; 11(1):47. PubMed ID: 27559359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma.
    Zhou P; Yu YF; Lian CL; Wang J; Zhuo RG; Wu SG
    Front Oncol; 2021; 11():668066. PubMed ID: 34136400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
    BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
    Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
    JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of high protein kinase CK2α in HPV(+) oropharyngeal squamous cell carcinoma and correlation with clinical outcomes.
    Trembley JH; Li B; Kren BT; Peltola J; Manivel J; Meyyappan D; Gravely A; Klein M; Ahmed K; Caicedo-Granados E
    PeerJ; 2021; 9():e12519. PubMed ID: 34993017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
    Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
    J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma.
    Alsbeih G; Al-Harbi N; Bin Judia S; Al-Qahtani W; Khoja H; El-Sebaie M; Tulbah A
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea.
    Jun HW; Ji YB; Song CM; Myung JK; Park HJ; Tae K
    Front Surg; 2021; 8():833048. PubMed ID: 35127812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.